Profile:

Roche Elecsys cardiac Troponin T-high sensitive

Faster diagnosis of acute myocardial infarction

Make a difference when every minute counts.

In the case of suspected AMI, prompt treatment is essential. Every 30 minutes of delay between symptoms and treatment increases the 1-year mortality rate by 7.5%.⁴

Troponin is the preferred biomarker in defining AMI according to the European Society of Cardiology (ESC) guidelines.⁵ In addition, it is the gold standard to distinguish between AMI and non-AMI patients.^5,6

Roche Elecsys cardiac Troponin T-high sensitive (TnT-hs) can reduce the time needed to rule-in or rule-out NSTEMI to as little as just 1 hour.^1-3

Do you have any questions?

Early and effective diagnosis with RocheElecsys cardiac Troponin T-high sensitive^7-9

As supported by the use of the 0/1 hour rule-in and rule-out algorithm recommended by international guidelines⁵

Safely reduce time to diagnosis

Triage over 75% of patients within 1 hour as validated by three multicentre studies with over 3,000 patients^7-9
Safely rule-out AMI and confidently discharge patients based on a high negative predictive value (99.1% - 100%) and low 30 day mortality rate (0.0% - 0.2%)^7-9

Lower the need for cardiac stress testing

Significantly reduce the need for cardiac stress testing by exercise electrocardiogram (ECG)¹⁰

Shorten stays in the emergency department (ED)

Facilitate early discharge or transfer from the ED by reducing time spent in ED by 2.1 hours (33%) vs standard practice¹¹

Download the PDF to learn more about how Roche Elecsys cardiac Troponin T-high sensitive can help support your clinical decisions.

Download PDF

Roche Troponin T-high sensitive (TnT-hs)

Assay specifications

Assay time

9 minute STAT 18 minutes routine assay
99th percentile upper reference limit

14 ng/L (pg/mL)
10% CV precision

13 ng/L (pg/mL)
Sample material

Heparin, EDTA plasma and serum

Abbreviations

NSTEMI: non–ST-segment elevation myocardial infarction

References

Bandstein et al. (2014). J Am Coll Cardiol 63, 2569-2578
Body et al. (2015). Clin Chem 61, 983-989
Rubini-Giménezet al. (2013). Int J Cardiol 168, 3896-3901
De Luca et al. (2004). Circulation 109, 1223-1225
Roffi et al. (2016). Eur Heart J 37, 267-315
Neumann et al. (2017). PLoS One 12:e0174288
Reichlin et al. (2012). Arch Intern Med 172, 1211-1218
Reichlin et al. (2015). CMAJ 187, E243-E252
Mueller et al. (2016). Annal Emerg Med 68, 76-87
Twerenbold et al. (2016). Eur Heart J 37, 3324-3332
Ambavane et al. (2017). PLoS One 12, e0187662